UCP2 and urinary bladder carcinoma: In addition, in pancreatic adenocarcinoma, non-small cell lung adenocarcinoma, and bladder carcinoma cell lines IC50 values of the anticancer drug gemcitabine increase with intrinsic UCP2 mRNA abundance.